Select for export The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/07067437221111371 PubMed 35975555 Copy citation Copy BibTeX Unknown journal 2022-08-16 Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D Europe PMC Published psilocybin DepressionAnxietyHeadache / Migraine Randomized Controlled Trial More
Select for export Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s11920-022-01361-0 PubMed 35953638 Copy citation Copy BibTeX Unknown journal 2022-08-11 Prouzeau D, Conejero I, Voyvodic PL, Becamel C, Abbar M, Lopez-Castroman J. Europe PMC Published psilocybin DepressionEnd-of-Life DistressMechanism of Action Clinical Trial More
Select for export Prophylactic Effects of Psilocybin on Chronic Cluster Headache: an Open-label Clinical Trial and Neuroimaging Study Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2022-08-09 Gitte Moos Knudsen ClinicalTrials.gov CLINICAL TRIAL psilocybinpsilocin Chronic PainHeadache / MigraineBrain Imaging Clinical Trial More
Select for export The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-022-06187-5 PubMed 35939083 Copy citation Copy BibTeX Psychopharmacology 2022-08-07 Watts R, Kettner H, Geerts D, Gandy S, Kartner L, Mertens L Europe PMC Published psilocybin DepressionEmotional ProcessingClinical Trial Randomized Controlled Trial More
Select for export Med Check: Psilocybin for OCD, Nuplazid Vote, and More Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2022.08.8.2 Copy citation Copy BibTeX Psychiatric News 2022-07-31 Terri D’Arrigo OpenAlex Published psilocybin DepressionOCDHeadache / Migraine Clinical Trial More
Select for export Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivity Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2022.07.10.22277414 Copy citation Copy BibTeX medRxiv 2022-07-09 Madsen MK, Petersen AS, Stenbæk DS, Sørensen IM, Schiønning H, Fjeld T medRxiv PREPRINT (not peer reviewed) psilocybin Headache / MigraineBrain ImagingMechanism of Action Clinical Trial More
Select for export Randomized Double Blind Placebo Controlled Assessing the Efficacy of Micro-dosed Psilocybin in Reducing Anxiety and or Depression Levels in Adults Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2022-06-29 Wake Network, Inc. ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyWellbeing Clinical Trial More
Select for export 3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.7759/cureus.26402 PubMed 35915689 Copy citation Copy BibTeX Unknown journal 2022-06-27 Inouye A, Wolfgang A. Europe PMC Published psilocybin DepressionPTSDClinical Trial Clinical Trial More
Select for export Psychedelics as preventive treatment in headache and chronic pain disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2022.109166 PubMed 35718005 Copy citation Copy BibTeX Unknown journal 2022-06-15 Schindler EAD. Europe PMC Published psilocybin Chronic PainHeadache / MigraineMechanism of Action Review Article More
Select for export The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1200/jco.2022.40.16_suppl.12097 Copy citation Copy BibTeX Journal of Clinical Oncology 2022-05-31 Manish Agrawal, Paul Thambi, Sarah Shnayder OpenAlex Published psilocybin DepressionAnxietyClinical Trial Clinical Trial More
Select for export Review of potential psychedelic treatments for PTSD. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jns.2022.120302 PubMed 35700643 Copy citation Copy BibTeX Unknown journal 2022-05-29 Henner RL, Keshavan MS, Hill KP. Europe PMC Published psilocybin PTSDMechanism of ActionClinical Trial Clinical Trial More
Select for export Psilocybin Versus Ketamine - Fast Acting Antidepressant Strategies in Treatment-resistant Depression Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2022-05-19 National Institute of Mental Health, Czech Republic ClinicalTrials.gov CLINICAL TRIAL psilocybinpsilocin DepressionNeuroplasticityBrain Imaging Clinical Trial More
Select for export The Efficacy of Psilocybin in the Treatment of Depression andAnxiety: A Meta-Analysis Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2174/2666082218666220513142002 Copy citation Copy BibTeX Current Psychiatry Research and Reviews 2022-05-15 Andrew Hodge, Suporn Sukpraprut-Braaten, Robert Strayhan OpenAlex Published psilocybin DepressionAnxietyReceptor Pharmacology Randomized Controlled Trial More
Select for export Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy in Major Depression Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2022-04-28 University of Zurich ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyNeuroplasticity Clinical Trial More
Select for export P388. Open Label Psilocybin Administration in Severely Treatment Resistant Depression No abstract availability was recorded for this entry. Details DOI 10.1016/j.biopsych.2022.02.624 Copy citation Copy BibTeX Biological Psychiatry 2022-04-27 Scott Aaronson, Tammy Miller, Samuel Rudow, MacKenzie Forbes, Trisha Suppes OpenAlex Published psilocybin DepressionAnxietyClinical Trial Randomized Controlled Trial More
Select for export Increased global integration in the brain after psilocybin therapy for depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41591-022-01744-z PubMed 35411074 Copy citation Copy BibTeX Nature Medicine 2022-04-10 Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D Europe PMC Published psilocybin DepressionBrain ImagingReceptor Pharmacology Randomized Controlled Trial More
Select for export Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel-Mediated Cardiotoxicity. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyab085 PubMed 34871422 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2022-03-31 Hackl B, Todt H, Kubista H, Hilber K, Koenig X. Europe PMC Published psilocybinpsilocin AgingClinical TrialSafety Clinical Trial More
Select for export Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3389/fphar.2021.788155 PubMed 35431912 Copy citation Copy BibTeX Frontiers in Pharmacology 2022-03-30 Murphy R, Kettner H, Zeifman R, Giribaldi B, Kartner L, Martell J Europe PMC Published psilocybin DepressionEmotional ProcessingMystical Experience Randomized Controlled Trial More
Select for export Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2022.04.4.35 Copy citation Copy BibTeX Psychiatric News 2022-03-23 Michael Avissar, Adrian Jacques H. Ambrose OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.nsa.2022.100104 PubMed 40656230 Copy citation Copy BibTeX Neuroscience Applied 2022-03-06 Mertens LJ, Koslowski M, Betzler F, Evens R, Gilles M, Jungaberle A Europe PMC Published psilocybin DepressionClinical TrialSafety Clinical Trial More
